Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036955	s-afmaksa	% (—)	79	86	100.00%	Distribution not available
3036955	s-afluu	% (—)	77	84	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal serum enzyme levels

20.73

11.82

2.3

2.5

—

Abnormal findings on examination of blood, without diagnosis

7.51

8.02

2.3

—

Diseases of liver

6.53

6.32

2.1

—

Pain in limb

2.96

4.09

2.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

8.75

3.77

2.6

2.3

—

Nausea and vomiting

5.88

3.75

2.2

2.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.60

3.60

2.1

2.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.98

3.56

2.1

2.2

—

Other diseases of liver

6.16

3.50

2.3

—

Symptoms and signs involving the skin and subcutaneous tissue

2.80

3.47

2.4

2.1

—

Liquid cancers, helper endpoint

5.23

3.40

2.4

2.1

—

Fitting and adjustment of other devices

4.14

3.38

2.2

2.3

—

Postmenopausal atrophic vaginitis

5.52

3.22

2.0

2.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.42

3.08

2.0

2.2

—

Headache

2.66

2.88

2.1

2.2

—

Gastro-oesophageal reflux disease

2.59

2.79

1.9

2.2

—

Other soft tissue disorders, not elsewhere classified

2.45

2.75

2.2

—

Gestational [pregnancy-induced] hypertension

4.20

2.67

2.5

2.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

3.31

2.43

2.3

2.2

—

Used for control exclusion in common control thyroid runs

2.33

2.40

2.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.29

2.38

2.1

—

Autoimmune diseases excluding thyroid diseases

2.28

2.36

2.1

—

Dermatitis and eczema

2.14

2.34

2.1

2.2

—

Diseases of oesophagus, stomach and duodenum

2.14

2.32

2.1

2.2

—

Other menopausal disorders

4.38

2.24

2.0

2.2

—

Abnormal findings on diagnostic imaging of other body structures

5.56

2.21

2.4

2.0

—

Budesonide

5.56

2.21

2.0

2.2

—

GASTRO-related operations

2.43

2.18

2.3

2.1

—

Any gastric operation

2.43

2.18

2.3

2.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

3.33

2.17

2.0

2.2

—

Speech therapy

3.69

2.15

2.4

2.1

—

Hypothyroidism, strict autoimmune

2.36

2.08

2.3

2.2

—

Aplastic and other anaemias

3.11

2.01

2.0

2.2

—

Depression medications

3.91

2.01

2.3

2.0

—

Bacterial infection, other or unspecified

2.51

1.96

2.2

2.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.65

1.89

2.5

2.2

—

Coxibs

5.27

1.89

2.0

2.4

—

Other diseases of pleura

3.23

1.87

2.3

2.1

—

Antihypertensive medication - note that there are other indications

2.45

1.82

2.3

2.2

—

Persons encountering health services in other circumstances, wide

2.01

1.79

2.0

2.2

—

Bacterial infection, other or unspecified

2.48

1.65

2.2

2.1

—

Other and unspecified iron deficiency

2.80

1.64

1.9

2.3

—

Constipation

1.98

1.64

1.9

2.2

—

Abnormal findings on diagnostic imaging of lung

2.56

1.63

2.0

2.2

—

General examination and investigation of persons without complaint and reported diagnosis

2.48

1.62

2.1

2.2

—

Oral corticosteroids

1.94

1.60

2.1

2.2

—

Zoster [herpes zoster]

2.34

1.59

2.2

2.1

—

General symptoms and signs

1.92

1.58

2.2

—

Major coronary heart disease event excluding revascularizations

0.00

1.57

0.0

2.0

—

Dental caries

3.43

1.55

2.4

2.1

—

Neoplasms

2.15

1.54

2.5

2.0

—

Acute tubulo-interstitial nephritis

2.27

1.54

2.0

2.2

—

Anaemias

3.63

1.53

1.8

2.0

—

Persons encountering health services for specific procedures and health care

1.86

1.53

2.1

2.2

—

First line medication for Crohn's disease

1.91

1.52

2.0

2.2

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

3.33

1.52

2.0

2.1

—

Medical treatment for female infertility

3.31

1.51

2.0

2.3

—

Diseases of salivary glands

2.59

1.51

2.0

2.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.43

1.47

2.0

2.1

—

Acute bronchitis

2.54

1.47

2.0

2.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.90

1.47

2.3

2.1

—

Malaise and fatigue

2.41

1.46

2.2

—

Other nutritional deficiencies

2.05

1.45

2.5

2.1

—

Iridocyclitis

3.13

1.44

2.4

2.3

—

Soft tissue disorders

1.92

1.43

2.3

2.2

—

Basal cell carcinoma

2.55

1.42

2.0

2.1

—

Diseases of the musculoskeletal system and connective tissue

2.38

1.41

2.2

2.4

—

ILD medications

1.84

1.39

2.0

2.2

—

Sciatica+with lumbago

2.24

1.38

2.0

2.2

—

Autoimmune diseases

1.89

1.38

2.3

2.1

—

Chronic diseases of tonsils and adenoids

1.90

1.37

1.9

2.2

—

Disorders of breast

2.08

1.37

2.4

2.1

—

Disorders of skin appendages

2.19

1.36

2.7

2.1

—

Injuries to the neck

2.94

1.36

2.0

2.4

—

Other diseases of blood and blood-forming organs, wide

2.94

1.36

2.0

2.2

—

Chronic gastritis

2.94

1.36

2.4

2.1

—

Excluding asthma or asthma-COPD overlap

2.04

1.35

2.1

2.3

—

Other pulmonary diagnosis

2.04

1.35

2.1

2.3

—

Codes for special purposes

2.14

1.33

2.4

2.1

—

Provisional assignment of new diseases of uncertain etiology

2.14

1.33

2.4

2.1

—

Hypothyroidism and >3 levothyroxin purchases

3.14

1.33

2.8

2.0

—

Hypothyroidism, levothyroxine purchases

3.14

1.33

2.8

2.0

—

Hypothyroidism (congenital or acquired)

3.14

1.33

2.8

2.0

—

Other disorders of urethra and urinary system

2.01

1.32

2.0

2.2

—

Other diseases of urinary system

1.83

1.31

2.0

2.2

—

Female infertility

3.04

1.30

2.0

2.4

—

Renal failure

2.53

1.30

2.3

2.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.83

1.29

2.0

2.2

—

Other and unspecified anaemias

2.49

1.29

2.0

2.2

—

Covid-19 suspected case

2.78

1.28

2.0

2.3

—

Disturbances of skin sensation

2.78

1.28

2.0

2.2

—

Diagnoses used for exclusion with ILD

2.78

1.28

2.0

2.2

—

Other anaemias

2.48

1.28

2.0

2.2

—

Other diseases of anus and rectum

2.77

1.28

2.4

2.1

—

Viral infections characterized by skin and mucous membrane lesions

1.84

1.26

2.1

2.2

—

COPD differential diagnosis

1.97

1.26

2.1

2.2

—

ILD differential diagnosis

1.97

1.26

2.1

2.2

—

Bronchitis

1.75

1.25

2.0

2.2

—

Malignant neoplasm

1.88

1.25

2.1

—

Postmenopausal bleeding

2.96

1.25

2.4

2.2

—

Malignant neoplasm, wide definition for exclusion

1.87

1.22

2.1

—

Pain, not elsewhere classified

2.63

1.21

2.4

2.1

—

Fever of other and unknown origin

2.16

1.20

2.3

2.2

—

Obesity due to excess calories

2.11

1.18

2.5

2.1

—

Degeneration of macula and posterior pole

0.00

1.18

0.0

2.1

—

Any event in cancer register

1.83

1.17

2.1

—

Other diseases of intestines

1.75

1.15

2.3

2.1

—

Acute upper respiratory infections of multiple and unspecified sites

1.89

1.15

2.0

2.2

—

Basal cell carcinoma, including avohilmo

2.41

1.14

2.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.40

1.14

2.0

—

Renal tubulo-interstitial diseases

1.83

1.13

2.2

—

Other heart diseases

2.04

1.13

2.6

2.1

—

Other reaction to severe stress, and adjustment disorders

2.33

1.12

2.3

2.1

—

Medical observation and evaluation for suspected diseases and conditions

2.19

1.11

2.3

2.2

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.98

1.10

2.4

2.1

—

COPD/asthma/ILD related infections

1.70

1.10

2.0

2.2

—

COPD/asthma related infections

1.70

1.10

2.0

2.2

—

Persons encountering health services for examination and investigation

2.15

1.10

2.2

—

Irritable bowel syndrome

2.38

1.09

2.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.96

1.09

2.2

—

Acute sinusitis

1.95

1.08

2.1

2.2

—

Symptoms and signs involving the digestive system and abdomen

1.80

1.07

2.3

2.2

—

Iron deficiency anaemia

2.16

1.06

1.9

2.2

—

Genitourinary diseases

2.51

1.05

2.0

2.6

—

Pregnancy hypertension

2.02

1.05

2.4

2.1

—

Inflammatory bowel disease treatment related agents

1.69

1.04

2.0

2.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.96

1.03

2.0

2.1

—

Gonarthrosis, primary, with knee surgery

1.89

1.00

2.2

—

Pain (limb, back, neck, head abdominally)

1.90

0.99

2.2

—

Nutritional anaemias

1.98

0.99

1.9

2.2

—

Certain infectious and parasitic diseases

1.67

0.98

2.1

2.2

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2.17

0.98

2.0

2.1

—

Other acute lower respiratory infections

1.96

0.97

2.0

2.2

—

Dorsopathies

1.69

0.97

2.1

2.2

—

Retinal detachments and breaks

0.00

0.97

0.0

2.1

—

Insulin, intermediate and long-acting

1.94

0.96

2.3

2.1

—

Disorders of other endocrine glands

1.91

0.95

1.7

2.2

—

ILD medications: immunosuppressive drugs

1.78

0.95

2.0

2.2

—

Presence of other functional implants

1.87

0.94

2.4

2.1

—

Other diseases of upper respiratory tract

1.63

0.93

1.9

2.3

—

Autoimmune diseases related-to ILD

1.68

0.92

2.2

—

Low back pain

1.79

0.92

2.0

2.3

—

Obesity, other/unspecified

2.14

0.91

2.3

2.1

—

Injuries to the wrist and hand

0.47

0.91

2.4

2.1

—

Diaphragmatic hernia

2.07

0.89

1.8

2.1

—

Artificial joint operation, meniscal resection

1.65

0.89

2.1

—

Abnormalities of breathing

1.66

0.88

2.1

2.2

—

Other/unspecified dorsalgia

2.05

0.88

2.0

2.3

—

Obesity and other hyperalimentation

1.78

0.87

2.4

2.1

—

Asthma (only as main-diagnosis), excluding more controls

1.84

0.87

2.0

2.3

—

Endocrine, nutritional and metabolic diseases

1.80

0.86

2.4

2.1

—

Dermatophytosis

1.82

0.85

2.3

2.1

—

Sleep apnoea, including avohilmo

1.60

0.85

2.3

2.1

—

Chronic periodontitis, including avohilmo

1.62

0.84

2.3

2.1

—

Asthma (only as main-diagnosis)

1.81

0.83

2.0

2.3

—

Coxarthrosis, primary, with hip surgery

1.87

0.81

2.0

2.1

—

Triptan medication for migraine, single purchase ok

1.63

0.80

2.2

2.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.63

0.80

2.2

2.1

—

Intestinal infectious diseases

1.62

0.80

2.2

—

Suicide or other Intentional self-harm

0.00

0.79

0.0

2.2

—

Type of accident

0.00

0.79

0.0

2.3

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

0.00

0.79

0.0

2.2

—

Myocardial infarction

0.00

0.79

0.0

2.1

—

Periodontitis

1.59

0.79

2.3

2.1

—

Other bacterial diseases

1.56

0.78

2.2

2.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

0.00

0.78

0.0

2.1

—

Use of hypnotics and sedatives

1.57

0.78

2.0

2.2

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.58

0.78

2.3

2.1

—

Lower back pain or/and sciatica

1.55

0.78

2.0

2.2

—

Osteopathies and chondropathies

1.66

0.78

2.1

2.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

0.00

0.77

0.0

2.3

—

Any reimbursement code in KELA

1.73

0.77

2.4

2.0

—

L02BG Aromatase inhibitors

1.76

0.76

2.7

2.0

—

Malignant neoplasm of skin

1.92

0.75

2.0

—

Voice disturbances

2.08

0.74

2.0

2.1

—

Parasetamol

1.69

0.73

2.4

2.2

—

Hypothyroidism, other/unspecified

1.58

0.73

2.3

2.1

—

Inflammatory bowel disease

2.00

0.72

2.4

2.2

—

Covid-19 confirmed case

2.00

0.72

2.8

2.2

—

Obesity

1.61

0.72

2.4

2.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.54

0.71

2.4

2.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.92

0.70

3.2

2.1

—

Selective serotonin reuptake inhibitors

1.55

0.70

2.1

2.2

—

Solid cancers, helper endpoint

1.61

0.70

2.1

—

Opioids

1.53

0.70

2.2

—

Persons with potential health hazards related to communicable diseases

1.91

0.70

2.4

2.2

—

Other and unspecified dermatitis

1.71

0.69

2.0

2.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.70

0.69

2.0

2.3

—

Appendectomy

1.65

0.69

2.1

2.2

—

Complications of surgical and medical care, not elsewhere classified

1.52

0.68

2.1

2.2

—

Atrial fibrillation and flutter with reimbursement

1.87

0.68

2.4

2.1

—

All kidney diseases

1.52

0.68

2.1

2.2

—

Sleep disorders

1.54

0.67

2.2

2.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.64

0.67

2.3

2.1

—

Disorders of sclera, cornea, iris and ciliary body

1.63

0.66

2.6

2.1

—

Disorders of the thyroid gland

1.54

0.66

2.3

2.1

—

Benzodiazepine use

1.51

0.66

2.0

2.2

—

Syncope and collapse

1.78

0.65

2.4

2.2

—

Coxarthrosis

1.70

0.64

2.0

2.2

—

Symptoms and signs involving speech and voice

1.72

0.64

2.0

2.1

—

Fracture of shoulder and upper arm

1.72

0.63

2.8

2.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.49

0.63

2.1

2.2

—

Dermatitis

1.63

0.61

2.0

2.2

—

1.45

0.61

2.0

2.2

—

Falls/tendency to fall

0.59

0.61

2.4

2.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.61

0.0

2.2

—

Coxarthrosis [arthrosis of hip](FG)

1.56

0.60

2.0

2.2

—

Other noninfective gastroenteritis and colitis

0.00

0.60

0.0

2.1

—

Poisoning by medicine

0.00

0.60

0.0

2.3

—

Poisoning by drugs, medicaments and biological substances

0.00

0.60

0.0

2.3

—

Asthma (mode)

1.62

0.60

2.0

2.2

—

Sulfasalazine

0.00

0.60

0.0

2.2

—

Abdominal and pelvic pain

1.55

0.60

2.3

2.2

—

Neurotic, stress-related and somatoform disorders

1.49

0.59

2.3

2.1

—

Alcohol dependence

0.00

0.59

0.0

2.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.77

0.59

2.3

2.0

—

Anxiety disorders

1.48

0.59

2.3

2.1

—

Salpingitis and oophoritis

0.00

0.58

0.0

2.0

—

Malignant neoplasm of breast, HER-positive

1.73

0.58

2.7

2.0

—

Asthma, including avohilmo

1.43

0.58

2.0

2.2

—

Care involving use of rehabilitation procedures

1.50

0.58

2.1

2.2

—

Malignant neoplasm of breast, ER-positive, including Hilmo

1.71

0.58

2.7

2.0

—

Diseases of the respiratory system

1.55

0.56

2.0

2.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.46

0.55

2.2

2.1

—

Asthma, excluding more controls

1.51

0.55

2.0

2.3

—

Cardiovascular diseases

1.51

0.55

2.4

2.2

—

Carpal tunnel syndrome

1.53

0.55

2.2

2.1

—

Asthma

1.47

0.54

2.0

2.3

—

Cystitis

1.52

0.54

2.2

—

Exposure to other specified factors

1.53

0.53

2.2

—

Gonarthrosis,primary

1.46

0.53

2.1

—

Atrial fibrillation and flutter

1.56

0.53

2.3

2.1

—

Visual disturbances

1.50

0.51

2.0

2.1

—

Medicines for HER+ breast cancer

1.50

0.51

2.7

2.0

—

Other antidepressants

1.45

0.50

2.3

2.2

—

Gastrointestinal diseases

1.59

0.50

2.3

2.0

—

Injuries to the shoulder and upper arm

1.48

0.50

2.4

2.1

—

Cholelithiasis

1.45

0.50

2.3

2.1

—

Diseases of the eye and adnexa

1.47

0.49

2.3

2.1

—

Dorsalgia

1.46

0.49

2.2

—

Insulin medication

1.55

0.49

2.3

2.1

—

Disorders of vitreous body

1.54

0.48

2.3

2.1

—

Disorders of vitreous body and globe

1.53

0.48

2.3

2.1

—

Other heart diseases, wide

1.42

0.48

2.5

2.1

—

Intestinal infectious diseases

1.38

0.48

2.1

2.2

—

Acute appendicitis, no complications

1.51

0.48

2.1

2.2

—

Insomnia

1.43

0.48

2.0

2.1

—

Sleep disorders (combined)

1.38

0.47

2.3

2.1

—

Contraceptive management

1.44

0.46

2.3

2.1

—

Malignant neoplasm of breast, HER2-negative

1.43

0.46

2.4

2.0

—

Malignant neoplasm of breast

1.43

0.46

2.4

2.0

—

Nerve, nerve root and plexus disorders

1.38

0.46

2.3

2.1

—

Necrosis of pulp, including avohilmo

1.40

0.45

2.3

2.1

—

Other dorsopathies, not elsewhere classified

1.43

0.44

1.9

2.3

—

Mycoses

1.43

0.44

2.2

2.1

—

Hypertensive diseases (excluding secondary)

1.50

0.44

2.8

2.1

—

Ischemic heart diseases

0.64

0.44

2.3

2.1

—

Type 2 diabetes, wide definition

1.44

0.44

2.4

2.1

—

Procreative management

1.60

0.43

2.4

2.1

—

Viral infections characterized by skin and mucous membrane lesions

1.61

0.43

2.4

2.1

—

Mouth breathing

1.61

0.43

2.0

2.1

—

Infections with a predominantly sexual mode of transmission

1.61

0.43

2.4

2.1

—

Codeine

1.38

0.42

2.3

2.2

—

Anxiety disorders, excluding more controls

1.39

0.42

2.3

2.1

—

Conduction disorders

0.00

0.41

0.0

2.0

—

Diabetes mellitus in pregnancy

1.52

0.41

2.8

2.0

—

Corneal ulcer

0.00

0.41

0.0

2.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.41

0.0

2.3

—

HSIL lesion of the cervix uteri

0.00

0.41

0.0

2.3

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.41

0.0

2.2

—

Other fall from one level to another

0.00

0.41

0.0

2.3

—

Diverticular disease of intestine

1.34

0.40

2.3

2.1

—

Car occupant injured in other and unspecified transport accidents

0.00

0.40

0.0

2.4

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.40

0.0

2.3

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.40

0.0

2.2

—

Cardiovascular diseases (excluding rheumatic etc)

1.40

0.39

2.4

2.1

—

Acute alcohol intoxication

0.00

0.39

0.0

2.2

—

Cholelithiasis, broad definition with cholecystitis

1.37

0.38

2.3

2.1

—

Dizziness and giddiness

1.32

0.37

2.1

2.2

—

Arthrosis

1.30

0.37

2.1

2.2

—

Chronic apical periodontitis

1.33

0.37

2.3

2.1

—

All chronic kidney diseases

1.36

0.37

2.4

2.1

—

Other intervertebral disc disorders

1.29

0.37

2.2

2.3

—

Asthma, unspecified (mode), excluding more controls

1.45

0.36

2.0

2.3

—

Disorders of vestibular function (Vertigo)

1.44

0.35

2.0

—

Asthma, unspecified (mode)

1.41

0.35

2.0

2.3

—

Injuries to the knee and lower leg

1.30

0.35

2.0

2.2

—

Other and unspecified disorders of vitreous body

1.41

0.35

2.0

2.1

—

Disorders of gallbladder, biliary tract and pancreas

1.32

0.34

2.3

2.1

—

Accidents

0.65

0.34

2.2

—

Other external causes of accidental injury

0.65

0.34

2.2

—

Spondylosis

1.36

0.34

2.0

2.2

—

Symptoms and signs involving the circulatory and respiratory systems

1.33

0.34

2.1

2.2

—

Emergency coronary revascularization (for ACS)

0.69

0.34

2.3

2.1

—

Infections of the skin and subcutaneous tissue

1.35

0.34

2.3

2.1

—

Major coronary heart disease event

0.66

0.34

2.3

2.1

—

Visual disturbances and blindness

1.33

0.33

2.0

2.2

—

Excessive earwax

1.33

0.33

2.0

2.1

—

Neurological diseases

1.34

0.33

2.5

2.0

—

Acute upper respiratory infections

1.31

0.33

2.0

2.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.32

0.32

2.0

2.2

—

Pain in throat and chest

1.35

0.32

2.1

2.2

—

L04AX Other immunosuppressants

1.28

0.32

2.0

2.2

—

Dyspnoea

1.33

0.31

2.2

2.1

—

Coxarthrosis, primary

1.35

0.31

2.0

2.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1.29

0.30

2.4

2.0

—

Malignant neoplasm of breast, including Hilmo

1.29

0.30

2.4

2.0

—

Asthma, hospital admissions , main diagnosis only

1.34

0.30

2.0

2.2

—

Complications of procedures, not elsewhere classified

1.33

0.29

2.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.30

0.29

2.1

2.2

—

Migraine

1.23

0.29

2.3

2.1

—

Any mental disorder

0.76

0.29

2.2

2.1

—

Other arrhythmias

1.31

0.28

2.3

2.0

—

Shoulder lesions

1.24

0.27

2.1

—

Sensorineural hearing loss

0.69

0.26

2.2

2.1

—

Triptan medication for migraine, min. 3 purchases

1.20

0.26

2.0

2.2

—

Hernia

1.29

0.26

1.9

2.2

—

Conductive and sensorineural hearing loss

0.66

0.26

2.2

2.1

—

Cardiac arrhythmias

1.27

0.26

2.2

2.1

—

Complications of medical and surgical care

0.69

0.26

2.4

2.1

—

Appendicitis, broad definition

1.25

0.25

2.1

2.2

—

Diseases of appendix

1.25

0.25

2.1

2.2

—

Arthropathies

1.30

0.25

2.4

2.2

—

Percutaneous Coronary Intervention

0.71

0.24

2.3

2.1

—

Coronary revascularization (ANGIO or CABG)

0.71

0.24

2.3

2.1

—

Finngen Rheumatological endpoints

1.26

0.24

2.0

2.2

—

Other abnormal products of conception

1.38

0.24

2.0

2.2

—

Diabetes medication

1.24

0.23

2.3

2.1

—

Hard cardiovascular diseases

0.75

0.23

2.1

—

Other disorders of ear

0.74

0.23

2.1

—

Other anxiety disorders

1.27

0.23

2.8

2.1

—

Noninfective enteritis and colitis

1.25

0.22

2.4

2.2

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.21

0.22

2.0

2.1

—

Outcome of delivery

0.00

0.21

0.0

2.3

—

Later onset COPD

0.00

0.21

0.0

2.2

—

Other bacterial diseases

1.25

0.21

2.2

2.1

—

Other abnormal uterine and vaginal bleeding

0.00

0.21

0.0

2.2

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.21

0.0

2.2

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

0.21

0.0

2.4

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.21

0.0

2.4

—

Operations 2 for CAVS

0.00

0.21

0.0

2.4

—

Calcific aortic valvular stenosis

0.00

0.21

0.0

2.4

—

Calcific aortic valvular stenosis, operated

0.00

0.21

0.0

2.4

—

Graves disease, strict definition

0.00

0.21

0.0

2.2

—

Psoriatic and enteropathic arthropathies

0.00

0.21

0.0

2.0

—

Sarcoidosis

0.00

0.21

0.0

2.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

2.0

—

Lateral epicondylitis

0.00

0.21

0.0

2.1

—

Hallux rigidus

0.00

0.21

0.0

1.9

—

Lesion of ulnar nerve

0.00

0.21

0.0

2.2

—

0.00

0.21

0.0

2.4

—

Thyrotoxicosis with diffuse goitre

0.00

0.21

0.0

2.1

—

Trigger finger

0.00

0.21

0.0

2.1

—

Methotrexate

0.00

0.21

0.0

2.1

—

Injury of eye and orbit

0.00

0.21

0.0

2.2

—

Unspecified acute lower respiratory infection

0.00

0.21

0.0

2.2

—

Alcohol abuse, main dg

0.00

0.21

0.0

2.2

—

severe traumatic brain injury, does not include concussion

0.00

0.21

0.0

2.4

—

Acute pancreatitis (for exclusion)

0.00

0.21

0.0

2.2

—

Nontraumatic intracranial haemmorrhage

0.00

0.21

0.0

2.4

—

Peritonsillar abscess

0.00

0.21

0.0

2.5

—

Gout, idiopatic and unspecified

0.00

0.21

0.0

2.4

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.21

0.0

2.4

—

Other hammer toe(s) (acquired)

0.00

0.21

0.0

1.9

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.21

0.0

2.3

—

Benign neoplasm of breast

0.00

0.21

0.0

2.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

0.21

0.0

2.2

—

Alcohol abuse, main dg, excluding more controls

0.00

0.21

0.0

2.2

—

Atrophic disorders of skin

0.00

0.21

0.0

2.0

—

Tumor necrosis factor alpha inhibitors

0.00

0.21

0.0

2.2

—

Acute alcohol intoxication, ICD10

0.00

0.21

0.0

2.2

—

Acute pancreatitis

0.00

0.21

0.0

2.3

—

0.00

0.20

0.0

2.2

—

Gonarthrosis [arthrosis of knee](FG)

1.26

0.20

2.1

2.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.22

0.20

2.2

2.1

—

Retained placenta and membranes, without haemorrhage

0.00

0.20

0.0

2.1

—

Retinal breaks without detachment

0.00

0.20

0.0

2.1

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.20

0.0

2.1

—

Aneurysms, operations, SAH

0.00

0.20

0.0

2.1

—

Biological medication for rheuma

0.00

0.20

0.0

2.3

—

Second line medication for Crohn's disease

1.22

0.20

2.0

2.2

—

Diseases of inner ear

1.21

0.20

2.0

2.1

—

Atopic dermatitis

1.20

0.20

2.0

2.2

—

Glaucoma

1.20

0.19

2.3

2.1

—

Other arthrosis

1.19

0.19

2.2

2.1

—

Tonsillectomy and adenotomy

1.16

0.19

1.8

2.2

—

Reimbursement for rheumatic diseases

1.17

0.19

2.0

2.2

—

Missing teeth due to accident, extraction or parodontitis

1.15

0.19

2.3

2.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.24

0.19

2.6

2.1

—

Asthma (diagnoses ohter than nonallergic)

1.24

0.18

2.0

2.2

—

All anxiety disorders

1.23

0.18

2.6

2.1

—

Injuries to the ankle and foot

1.15

0.17

2.3

2.1

—

Other specific joint derangements/joint disorders

0.75

0.17

2.0

2.2

—

Gonarthrosis

1.20

0.17

2.1

2.2

—

Symptoms and signs involving the urinary system

0.76

0.17

1.8

2.2

—

Allergic conjunctivitis

0.76

0.17

2.0

2.2

—

Statin medication

1.15

0.17

2.5

2.1

—

Acute appendicitis

1.19

0.16

2.1

2.2

—

Heart failure, not strict

1.16

0.16

2.3

2.1

—

Dental caries, including avohilmo

1.18

0.16

2.4

2.1

—

Tramadol

0.77

0.16

2.0

2.1

—

Type 2 diabetes

1.19

0.15

2.3

2.1

—

Exclusions for E4_PCOS_CONSORTIUM

0.80

0.15

2.1

2.2

—

Diseases of the skin and subcutaneous tissue

1.20

0.15

2.4

2.1

—

Psychiatric diseases

1.18

0.14

2.2

—

Depression

1.18

0.13

2.4

2.1

—

Diseases of pulp and periapical tissues, including avohilmo

1.17

0.13

2.5

2.1

—

Codeine or tramadol medication

1.15

0.11

2.3

2.1

—

Diabetes, varying definitions

1.15

0.11

2.3

2.1

—

Asthma/COPD (KELA code 203)

1.16

0.11

2.0

2.2

—

Diabetes mellitus

1.15

0.11

2.3

2.1

—

Pain in joint

1.14

0.10

2.0

2.2

—

Primary gonarthrosis, bilateral

1.13

0.10

2.4

2.2

—

Other headache syndromes

1.14

0.10

2.0

2.1

—

Polycystic ovarian syndrome, consortium definition

1.16

0.10

2.4

2.1

—

Meniscus derangement

1.12

0.09

2.3

2.2

—

Dislocation, sprain and strain of joints and ligaments of knee

1.04

0.08

2.0

2.2

—

Irregular menses

1.03

0.08

2.7

2.1

—

Spondylopathies

0.77

0.08

2.0

2.2

—

Benign neoplasm of colon, rectum, anus and anal canal

1.02

0.08

2.0

2.2

—

Other disorders of skin and subcutaneous tissue

0.78

0.08

3.2

2.1

—

Anxiety (asthma-related co-morbidities)

1.10

0.08

2.6

2.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.78

0.08

2.0

2.1

—

Varicose veins

1.10

0.08

1.9

2.2

—

Implicit Sepsis

1.10

0.08

2.3

2.1

—

Pregnancy with abortive outcome

0.82

0.08

2.3

2.2

—

Medical abortion

0.86

0.08

2.0

2.2

—

Bleeding

0.84

0.08

2.7

2.1

—

Injuries to the elbow and forearm

0.82

0.07

2.2

—

Diseases of the ear and mastoid process

0.89

0.07

2.1

2.2

—

Leiomyoma of uterus

0.86

0.07

2.3

2.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.85

0.07

2.3

2.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.09

0.07

2.2

—

1.09

0.07

2.2

—

Artrosis, including avohilmo

1.07

0.07

2.1

2.2

—

Type 2 diabetes, definitions combined, including avohilmo

1.12

0.07

2.4

2.1

—

Hypertensive diseases

1.13

0.06

2.6

2.1

—

Pneumonias (Asthma/COPD co-morbidities)

0.89

0.06

2.2

2.1

—

Mood [affective] disorders

0.87

0.06

2.4

2.1

—

Mood disorders

0.87

0.06

2.4

2.1

—

Hypertension

1.13

0.06

2.6

2.1

—

Episodal and paroxysmal disorders

0.89

0.06

2.4

2.1

—

All pneumoniae

1.11

0.06

2.2

—

Dental pulpitis, including avohilmo

1.12

0.05

2.4

2.1

—

Gingivitis and periodontal diseases

0.92

0.03

2.2

2.1

—

Influenza and pneumonia

1.08

0.02

2.2

—

Fall on same level

1.04

0.00

2.3

2.1

—

Chronic lower respiratory diseases

0.98

0.00

2.0

2.2

—

Other (not insulin) diabetes medications

0.99

0.00

2.2

2.1

—

Biguanides

1.00

0.00

2.2

2.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.04

0.00

2.4

2.1

—

Type 2 diabetes, strict (exclude DM1)

1.01

0.00

2.2

2.1

—

Metabolic disorders

1.00

0.00

2.6

2.1

—

Type 2 diabetes, definitions combined

1.01

0.00

2.2

2.1

—

Diabetes, insulin treatment (Kela reimbursement)

0.99

0.00

2.4

2.1

—

Gout, strict definition

0.00

0.0

2.3

—

Problems related to lifestyle

0.00

0.0

2.4

—

Bitten or struck by other mammals

0.00

0.0

2.0

—

0.00

0.0

2.2

—

Idiopathic gout

0.00

0.0

2.3

—

0.00

0.0

2.4

—

Lumbar disc prolapse

0.98

0.00

2.0

2.2

—

Mood disorders, excluding more controls

0.91

0.00

2.4

2.1

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.0

2.4

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.0

2.3

—

Neuromuscular dysfunction of bladder

0.00

0.0

2.0

—

Congenital malformations, deformations and chromosomal abnormalities

0.84

0.00

2.4

2.1

—

Recurrent dislocation and subluxation of joint

0.00

0.0

2.0

—

Postprocedural disorders of nervous system

0.00

0.0

2.0

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

2.0

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.0

1.8

—

Retinal vascular disorders

0.00

0.0

2.0

—

Eustachian salpingitis and obstruction

0.00

0.0

2.0

—

Delirium, not induced by alcohol and other psychoactive substances

0.00

0.0

2.4

—

Retinal vascular occlusion

0.00

0.0

2.0

—

Hyperkinetic disorders, excluding more controls

0.00

0.0

2.0

—

Other disorders of the genitourinary system

0.00

0.0

2.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

2.0

—

Assault

0.00

0.0

2.0

—

Noninfectious colitis NAS

0.00

0.0

2.2

—

Enterocolitis due to Clostridium difficile

0.00

0.0

2.0

—

Asthma-related infections

1.02

-0.00

2.0

2.2

—

Pain in thoracic spine

0.00

-0.00

0.0

2.3

—

Other complications of surgical and medical care, not elsewhere classified

0.00

-0.00

0.0

2.0

—

Lichen sclerosus et atrophicus

0.00

-0.00

0.0

2.0

—

Monoamine oxidase A inhibitors

0.00

-0.00

0.0

2.4

—

Idiopathic pulmonary fibrosis

0.00

-0.00

0.0

2.0

—

Persons encountering health services in circumstances related to reproduction

0.96

-0.00

2.0

2.1

—

Acute laryngitis and tracheitis

0.00

-0.00

0.0

2.0

—

Polyarthropathies

0.98

-0.00

2.0

2.2

—

Erysipelas

1.02

-0.00

2.2

—

Metatarsalgia

0.00

-0.00

0.0

1.8

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.00

-0.00

0.0

2.2

—

Use of rivastigmine

0.00

-0.00

0.0

2.3

—

Other disorders of the musculoskeletal system and connective tissue

0.00

-0.00

0.0

2.2

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

-0.00

0.0

2.0

—

Inflammatory diseases of female pelvic organs

0.94

-0.00

2.0

2.1

—

Other maternal disorders predominantly related to pregnancy

0.93

-0.00

2.6

2.1

—

Use of other anti-dementia drugs

0.00

-0.00

0.0

2.3

—

Arthropathic psoriasis

0.00

-0.00

0.0

2.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.01

-0.00

2.4

2.1

—

Hyperkinetic disorders

0.00

-0.00

0.0

2.3

—

Disorder of lipoprotein metabolism, unspecified

0.00

-0.00

0.0

2.0

—

Depression or dysthymia

0.97

-0.00

2.0

2.2

—

Psoriatic arthropathies, ICD10

0.00

-0.00

0.0

2.0

—

Dermatophytosis

0.00

-0.00

0.0

2.3

—

Follow-up examination after treatment for malignant neoplasms

0.00

-0.00

0.0

2.0

—

Eating disorder

0.00

-0.00

0.0

2.4

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

2.0

—

Conjunctivitis

1.01

-0.00

2.3

2.1

—

Disturbance of activity and attention

0.00

-0.00

0.0

2.0

—

Disease of hard tissues of teeth, NOS

0.90

-0.00

2.4

2.2

—

Contact with machinery

0.00

-0.00

0.0

2.4

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

2.4

—

Peripheral arterial reconstruction

0.00

-0.00

0.0

2.5

—

Other keratitis

0.00

-0.00

0.0

2.3

—

Sleep apnoea

0.91

-0.00

2.4

2.1

—

Use of levodopa decarboxylase inhibitor

0.00

-0.00

0.0

2.0

—

Rotator cuff syndrome

0.94

-0.00

2.0

2.1

—

Macular pucker

0.00

-0.00

0.0

2.0

—

Other psoriatic arthropathies

0.00

-0.00

0.0

2.0

—

Otitis externa, unspecified

0.00

-0.00

0.0

2.0

—

Bell's palsy

0.00

-0.00

0.0

2.3

—

Benign neoplasm: Sigmoid colon

0.00

-0.00

0.0

2.3

—

Dentofacial anomalies [including malocclusion]

0.92

-0.00

2.9

2.1

—

Hypertension, essential

0.91

-0.00

2.5

2.1

—

Degenerative macular diseases

0.00

-0.00

0.0

2.0

—

Subarachnoid haemorrhage

0.00

-0.00

0.0

2.0

—

Congenital malformations of genital organs

0.00

-0.00

0.0

2.0

—

Intracerebral haemorrhage

0.00

-0.00

0.0

2.3

—

ILD medications: azathioprine

0.00

-0.00

0.0

2.3

—

Other specified/unspecified hearing loss

0.00

-0.00

0.0

2.0

—

Disorders of psychological development

0.00

-0.00

0.0

2.4

—

Coronary artery bypass grafting

0.00

-0.00

0.0

2.3

—

Myocardial infarction, unclassifiable

0.00

-0.00

0.0

2.5

—

Mixed conductive and sensorineural hearing loss

0.00

-0.00

0.0

2.0

—

Other and unspecified vascular occlusions

0.00

-0.00

0.0

2.0

—

Other disorders of conjunctiva

0.00

-0.00

0.0

2.0

—

Status post-ami

0.00

-0.00

0.0

2.4

—

Pneumonitis due to solids and liquids

0.00

-0.00

0.0

2.0

—

Disorders of conjunctiva

0.97

-0.00

2.3

2.1

—

Use of memantine

0.00

-0.00

0.0

2.3

—

Complications of labour and delivery

0.95

-0.00

2.0

2.2

—

Retinal detachment with retinal break

0.00

-0.00

0.0

2.3

—

Nonischemic cardiomyopathy

0.00

-0.00

0.0

2.0

—

Other sleep disorders

0.00

-0.00

0.0

2.0

—

Disorders of muscles

0.00

-0.00

0.0

2.0

—

Reactive arthropathies

0.00

-0.00

0.0

2.0

—

Inguinal hernia, bilateral

0.00

-0.00

0.0

2.4

—

Pneumonia, organism unspecified

0.97

-0.00

2.3

2.2

—

Inguinal or femoral hernia, bilateral

0.00

-0.00

0.0

2.4

—

Coeliac disease

0.00

-0.00

0.0

2.0

—

Other specified and unspecified personality disorders

0.00

-0.00

0.0

2.0

—

Azathioprine

0.00

-0.00

0.0

2.2

—

Gout, unspecified

0.00

-0.00

0.0

2.4

—

Other and unspecified injuries of lower leg

0.00

-0.00

0.0

2.0

—

Other embolism and thrombosis

0.00

-0.00

0.0

2.3

—

Other blood glucose lowering drugs, excl. Insulins

0.00

-0.00

0.0

2.3

—

Abnormal involuntary movements

0.00

-0.00

0.0

2.3

—

Prolonged pregnancy

0.00

-0.00

0.0

2.3

—

Infections of genitourinary tract in pregnancy

0.00

-0.00

0.0

2.0

—

ILD, hospital admission 2, with pulmonary infections

0.00

-0.00

0.0

2.8

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

2.0

—

Other obstetric trauma

0.00

-0.00

0.0

2.3

—

Abdominal aortic aneurysm (AAA)

0.00

-0.00

0.0

2.3

—

Eating disorders

0.00

-0.00

0.0

2.3

—

Superficial injury of thorax

0.00

-0.00

0.0

2.3

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

-0.00

0.0

2.0

—

Asthma, hospital admission 2, infections

1.02

-0.00

2.0

2.2

—

Undefined dementia

0.00

-0.00

0.0

2.4

—

Seronegative rheumatoid arthritis

0.00

-0.00

0.0

2.0

—

Other noninflammatory disorders of vagina

0.00

-0.00

0.0

2.4

—

Adenomyosis (Endometriosis of uterus)

0.00

-0.00

0.0

2.3

—

Other complications of labour and delivery, not elsewhere classified

0.00

-0.00

0.0

3.0

—

Caries of dentine, including avohilmo

1.00

-0.00

2.5

2.1

—

Burns and corrosions

0.00

-0.00

0.0

2.3

—

Deep endometriosis

0.00

-0.00

0.0

2.0

—

Excessive vomiting in pregnancy

0.00

-0.00

0.0

2.0

—

Wet age-related macular degeneration

0.00

-0.00

0.0

2.3

—

Benign neoplasms

0.90

-0.00

2.5

2.1

—

Other joint disorders

0.98

-0.00

2.5

2.2

—

Other respiratory disorders and diseases

0.00

-0.00

0.0

2.4

—

Thiazolidinediones

0.00

-0.00

0.0

2.4

—

Leisure time condition

0.00

-0.00

0.0

2.2

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

2.0

—

Carcinoma in situ of cervix uteri

0.00

-0.00

0.0

2.3

—

Psoriatic arthropathies

0.00

-0.00

0.0

2.0

—

Injury of muscle and tendon at wrist and hand level

0.00

-0.00

0.0

2.2

—

Polymyalgia rheumatica

0.00

-0.00

0.0

2.0

—

Open wound of lower leg

0.00

-0.00

0.0

2.3

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

-0.00

0.0

2.3

—

Fracture of lumbar spine and pelvis

0.00

-0.00

0.0

2.3

—

Other diseases of the respiratory system

0.00

-0.00

0.0

2.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.93

-0.00

2.2

—

Unspecified privation

0.00

-0.00

0.0

2.0

—

Dilated cardiomyopathy

0.00

-0.00

0.0

2.3

—

Fibromyalgia

0.00

-0.00

0.0

2.1

—

Orchitis and epididymitis

0.00

-0.00

0.0

2.4

—

Other condition

0.00

-0.00

0.0

2.3

—

Disorders of eyelid, lacrimal system and orbit

0.91

-0.00

2.5

2.1

—

Acute nasopharyngitis (common cold)

0.00

-0.00

0.0

2.3

—

Melanocytic naevi, other sites/unspecified

0.00

-0.00

0.0

2.0

—

Other puerperal infections

0.00

-0.00

0.0

2.3

—

Other noninflammatory disorders of vulva and perineum

0.00

-0.00

0.0

2.3

—

Diseases of the myoneural junction and muscle

0.00

-0.00

0.0

2.0

—

Cholecystectomy

0.97

-0.00

2.6

2.1

—

COPD-related respiratory insufficiency

0.00

-0.00

0.0

2.3

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

-0.00

0.0

2.0

—

STROKE

0.89

-0.00

1.8

2.2

—

Exposure to unspecified factor

0.92

-0.00

2.2

2.1

—

Adalimumab

0.00

-0.00

0.0

2.0

—

Uterine polyps

0.00

-0.00

0.0

2.3

—

Use of donepezil

0.00

-0.00

0.0

2.3

—

Impacted cerumen

0.00

-0.00

0.0

2.0

—

Lung cancer and mesothelioma

0.00

-0.00

0.0

2.3

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS